289 related articles for article (PubMed ID: 18712791)
1. Selection of high-avidity CD8 T cells correlates with control of hepatitis C virus infection.
Neveu B; Debeaupuis E; Echasserieau K; le Moullac-Vaidye B; Gassin M; Jegou L; Decalf J; Albert M; Ferry N; Gournay J; Houssaint E; Bonneville M; Saulquin X
Hepatology; 2008 Sep; 48(3):713-22. PubMed ID: 18712791
[TBL] [Abstract][Full Text] [Related]
2. Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073.
Fytili P; Dalekos GN; Schlaphoff V; Suneetha PV; Sarrazin C; Zauner W; Zachou K; Berg T; Manns MP; Klade CS; Cornberg M; Wedemeyer H
Vaccine; 2008 Jul; 26(31):3818-26. PubMed ID: 18582999
[TBL] [Abstract][Full Text] [Related]
3. Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution.
Neumann-Haefelin C; McKiernan S; Ward S; Viazov S; Spangenberg HC; Killinger T; Baumert TF; Nazarova N; Sheridan I; Pybus O; von Weizsäcker F; Roggendorf M; Kelleher D; Klenerman P; Blum HE; Thimme R
Hepatology; 2006 Mar; 43(3):563-72. PubMed ID: 16496339
[TBL] [Abstract][Full Text] [Related]
4. Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection.
Penna A; Pilli M; Zerbini A; Orlandini A; Mezzadri S; Sacchelli L; Missale G; Ferrari C
Hepatology; 2007 Mar; 45(3):588-601. PubMed ID: 17326153
[TBL] [Abstract][Full Text] [Related]
5. Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain.
Mikkelsen M; Holst PJ; Bukh J; Thomsen AR; Christensen JP
J Immunol; 2011 Feb; 186(4):2355-64. PubMed ID: 21257961
[TBL] [Abstract][Full Text] [Related]
6. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
[TBL] [Abstract][Full Text] [Related]
7. Positive selection of cytotoxic T lymphocyte escape variants during acute hepatitis C virus infection.
Guglietta S; Garbuglia AR; Pacciani V; Scottà C; Perrone MP; Laurenti L; Spada E; Mele A; Capobianchi MR; Taliani G; Folgori A; Vitelli A; Ruggeri L; Nicosia A; Piccolella E; Del Porto P
Eur J Immunol; 2005 Sep; 35(9):2627-37. PubMed ID: 16114108
[TBL] [Abstract][Full Text] [Related]
8. TCR-redirected human T cells inhibit hepatitis C virus replication: hepatotoxic potential is linked to antigen specificity and functional avidity.
Pasetto A; Frelin L; Aleman S; Holmström F; Brass A; Ahlén G; Brenndörfer ED; Lohmann V; Bartenschlager R; Sällberg M; Bertoletti A; Chen M
J Immunol; 2012 Nov; 189(9):4510-9. PubMed ID: 23024278
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the CD8-positive T cell response in Japanese patients with chronic hepatitis C using HLA-A*2402 peptide tetramers.
Nakamoto Y; Kaneko S; Takizawa H; Kikumoto Y; Takano M; Himeda Y; Kobayashi K
J Med Virol; 2003 May; 70(1):51-61. PubMed ID: 12629644
[TBL] [Abstract][Full Text] [Related]
10. Presence of effector CD8+ T cells in hepatitis C virus-exposed healthy seronegative donors.
Scognamiglio P; Accapezzato D; Casciaro MA; Cacciani A; Artini M; Bruno G; Chircu ML; Sidney J; Southwood S; Abrignani S; Sette A; Barnaba V
J Immunol; 1999 Jun; 162(11):6681-9. PubMed ID: 10352286
[TBL] [Abstract][Full Text] [Related]
11. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
[TBL] [Abstract][Full Text] [Related]
12. Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection.
Spangenberg HC; Viazov S; Kersting N; Neumann-Haefelin C; McKinney D; Roggendorf M; von Weizsäcker F; Blum HE; Thimme R
Hepatology; 2005 Oct; 42(4):828-37. PubMed ID: 16175596
[TBL] [Abstract][Full Text] [Related]
13. Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen.
Martin P; Parroche P; Chatel L; Barretto C; Beck A; Trépo C; Bain C; Lone YC; Inchauspé G; Fournillier A
J Med Virol; 2004 Nov; 74(3):397-405. PubMed ID: 15368525
[TBL] [Abstract][Full Text] [Related]
14. Characterization of HCV-specific Patr class II restricted CD4+ T cell responses in an acutely infected chimpanzee.
Woollard DJ; Grakoui A; Shoukry NH; Murthy KK; Campbell KJ; Walker CM
Hepatology; 2003 Nov; 38(5):1297-306. PubMed ID: 14578870
[TBL] [Abstract][Full Text] [Related]
15. Antigen-driven patterns of TCR bias are shared across diverse outcomes of human hepatitis C virus infection.
Miles JJ; Thammanichanond D; Moneer S; Nivarthi UK; Kjer-Nielsen L; Tracy SL; Aitken CK; Brennan RM; Zeng W; Marquart L; Jackson D; Burrows SR; Bowden DS; Torresi J; Hellard M; Rossjohn J; McCluskey J; Bharadwaj M
J Immunol; 2011 Jan; 186(2):901-12. PubMed ID: 21160049
[TBL] [Abstract][Full Text] [Related]
16. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C.
Nelson DR; Marousis CG; Davis GL; Rice CM; Wong J; Houghton M; Lau JY
J Immunol; 1997 Feb; 158(3):1473-81. PubMed ID: 9013994
[TBL] [Abstract][Full Text] [Related]
17. Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection.
Chang KM; Thimme R; Melpolder JJ; Oldach D; Pemberton J; Moorhead-Loudis J; McHutchison JG; Alter HJ; Chisari FV
Hepatology; 2001 Jan; 33(1):267-76. PubMed ID: 11124845
[TBL] [Abstract][Full Text] [Related]
18. Modulation of Hepatitis C Virus-Specific CD8 Effector T-Cell Function with Antiviral Effect in Infectious Hepatitis C Virus Coculture Model.
Ojiro K; Qu X; Cho H; Park JJ; Vuidepot A; Lissin N; Molloy PE; Bennett A; Jakobsen BK; Kaplan DE; Riley JL; Chang KM
J Virol; 2017 May; 91(10):. PubMed ID: 28275182
[TBL] [Abstract][Full Text] [Related]
19. Structural in silico analysis of cross-genotype-reactivity among naturally occurring HCV NS3-1073-variants in the context of HLA-A*02:01 allele.
Antunes DA; Rigo MM; Silva JP; Cibulski SP; Sinigaglia M; Chies JA; Vieira GF
Mol Immunol; 2011 Jul; 48(12-13):1461-7. PubMed ID: 21513985
[TBL] [Abstract][Full Text] [Related]
20. Cross-reactivity between hepatitis C virus and Influenza A virus determinant-specific cytotoxic T cells.
Wedemeyer H; Mizukoshi E; Davis AR; Bennink JR; Rehermann B
J Virol; 2001 Dec; 75(23):11392-400. PubMed ID: 11689620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
